• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problem Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/24/2020
Event Type  malfunction  
Manufacturer Narrative
A synergy ous mr 3.00 x 38 mm stent delivery system was returned for analysis.A visual examination of the stent found that the stent was damaged from mid-section of stent to the distal end, with stent struts lifted from crimped stent positions and misaligned.The undamaged crimped stent outer diameter measured and the result was within maximum crimped stent profile measurement.Stent damage most likely occurred when the stent struts got caught in the calcification.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the tip showed signs of damage on the distal edges of the tip.Tip damage most likely occurred when the tip was pushed against a restriction.A visual and tactile examination of the hypotube found multiple kinks along several locations of the hypotube shaft.This type of damage is consistent with excessive force that could have been applied to the delivery system.A visual and tactile examination of the outer extrusion, mid-shaft section, and visual examination of the inner extrusion found no issue with the extrusion shaft.No other issues were identified during the product analysis.
 
Event Description
Reportable based on device analysis completed on 03oct2020.It was reported that crossing difficulties were encountered.The 80% stenosed target lesion was located in the moderately tortuous and severely calcified right coronary artery.After the lesion was pre-dilated, a 3.00 x 38 synergy ii drug-eluting stent was advanced, but failed to cross the lesion.The procedure was completed with another of the same device.There were no patient complications reported.However, returned device analysis revealed stent damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key10730412
MDR Text Key212862669
Report Number2134265-2020-14717
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeKS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 10/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/15/2020
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0024020342
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/03/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age70 YR
-
-